Advicenne Presents 2019 Half-Year Financial Report and Confirms Financial Outlook

September 24, 2019

Advicenne (Euronext: ADVIC – FR0013296746), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for rare kidney disease, announces today its financial results for the six months ending on June 30, 2019, and confirms its operational outlook.